developing ideas. delivering innovation.
Newsroom
Press Releases | View All
- September 14, 2010 | Announcing the formation of Pavilion Medical Innovations, LLC
- April 28, 2010 | Vortex Medical’s AngioVac® Advances on Fast Track from Initial Funding to Human Use PPT
- April 28, 2010 | Pavilion Medical Innovations, LLC Launched to Assist Physician Inventors; Founders Fast-Tracked Development of Vortex Medical’s AngioVac®
April 28, 2010
Vortex Medical’s AngioVac® Advances on Fast Track from Initial Funding to Human Use PPT
Norwell, MA – April 28, 2010 – Vortex Medical Inc. has achieved an enviable track record in hitting key milestones for its initial product, the AngioVac® Cannula and Circuit. Mike Glennon, CEO of the company, said the innovative medical device was developed in a capital efficient and timely manner that has already enabled it to be utilized in the first Vortex human use PPT case.
Vortex Medical was founded in March 2008 with a $2.25 M investment from Catalyst Health Ventures. In June 2009, a U.S. patent was published for the AngioVac® Cannula and Circuit with Glennon listed as a co-inventor. The company received 510(k) FDA clearance for AngioVac’s use in the second half of 2009. The first Vortex human use PPT case was performed at the Brigham and Women’s Hospital, Boston, MA, in December of 2009.
Glennon, who has had 20-plus years in the medical device marketplace and is a co-founder of Vortex Medical, stated that a key to the fast-track development was involvement of Al Chin, MD, an MIT-trained engineer and Stanford-trained M.D. who is one of the most successful medical device inventors of our time with 165 U.S. Patents. Dr. Chin’s device designs have generated over $1.25 billion in revenue to date. His inventions have been used in more than one million endovein procedures.
A Director of Vortex Medical, Dr. Chin worked closely with Glennon in the design and development of AngioVac®. The AngioVac Suction Cannula has a balloon actuated, expandable, funnel-shaped distal tip to facilitate flow, and to facilitate en-bloc removal of undesirable intravascular material such as clots and emboli during the performance of extracorporeal circulation. It is used in conjunction with the AngioVac Circuit.
About Vortex Medical Inc.
Vortex Medical Inc. was founded in March 2008 by Pavilion Holdings Group LLC with an investment from Boston based venture firm Catalyst Health Ventures. Vortex Medical focuses on pioneering unique endovascular solutions to commonly occurring endovascular problems. The Vortex AngioVac Suction Cannula has a balloon actuated, expandable, distal tip to facilitate flow, and to facilitate en bloc removal of undesirable intravascular material during the performance of extracorporeal circulation.